Ohcanbohtosat - Coretta Thomas Robinson
- Čájehuvvo 1 - 2 / 2
-
1
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibrom... Dahkki Brian Weiss, Pamela L. Wolters, Scott R. Plotkin, Brigitte C. Widemann, James H. Tonsgard, Jaishri O. Blakeley, Jeffrey C. Allen, Elizabeth K. Schorry, Bruce R. Korf, Nathan Robison, Stewart Goldman, Alexander A. Vinks, Chie Emoto, Tsuyoshi Fukuda, Coretta Thomas Robinson, Gary Cutter, Lloyd J. Edwards, Eva Dombi, Nancy Ratner, Roger J. Packer, Michael J. Fisher
Almmustuhtton 2021Artigo -
2
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial Dahkki Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp
Almmustuhtton 2021Artigo